Recent News

By Category: Biotechnology

PharmAthene completes final commercial scale-up activities for SparVax

(Pharmaceutical Business Review) PharmAthene has accomplished significant progress in the development of SparVax, a second generation recombinant protective antigen (rPA) anthrax vaccine. PharmAthene's rPA anthrax vaccine program has been funded in whole or in part with Federal funds …

September 12, 2011
| Filed under North America, Biotechnology, and Countermeasures
Share

Regulating Synthetic Biology: How Much or How Little?

(Pharmaceutical Technology Magazine) That debate is taking shape not only broadly but in the nascent field of synthetic biology, where scientific, public-health, and business interests are converging. In a recently published paper in Science, the Biotechnology Industry Organization (BIO) …

September 6, 2011
| Filed under North America, Biosafety, and Biotechnology
Share

NIH May Grant Licenses to Produce Anthrax Vaccine

(Occupational Health & Safety) The National Institutes of Health announced that it may grant of an exclusive license to practice the inventions in several patent applications involving anthrax vaccines to Biologics Resources LLC, which is located in Boyds, Md. The patent rights in …

August 30, 2011
| Filed under North America, Biotechnology, and Countermeasures
Share

Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax …

Emergent BioSolutions Inc. announced today that results from a Phase 1a clinical trial evaluating an investigational anthrax vaccine, Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant mixed at bedside, …

August 29, 2011
| Filed under North America, Biotechnology, and Countermeasures
Share

Albany Lab Prepares to Ship Anthrax, Plague Strains to Pa.

(GSN Daily News) A soon-to-be-shuttered research institution in New York on Monday plans to ship disease materials that include anthrax and plague bacteria to the University of Pittsburgh in Pennsylvania, the Albany Times-Union reported (see GSN, March 18, 2009). The U.S. Centers of Disease Control and Prevention has authorized the bioagent transfer from the Center Read More »